1. Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
- Author
-
Jin Zou, Shuyan Chen, Weiqiao Rao, Liang Fu, Jiancong Zhang, Yunli Liao, Ying Zhang, Ning Lv, Guofang Deng, Shijin Yang, Liang Lin, Lujin Li, Siqi Liu, and Jiuxin Qu
- Subjects
Pharmacology ,Adult ,Infectious Diseases ,Transferases ,Tuberculosis, Multidrug-Resistant ,Antitubercular Agents ,Humans ,Pharmacology (medical) ,Diarylquinolines ,Tuberculosis, Pulmonary ,Polymorphism, Single Nucleotide - Abstract
Bedaquiline has been widely used as a part of combination dosage regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB) patients with limited options. Although the effectiveness and safety of bedaquiline have been demonstrated in clinical trials, limited studies have investigated the significant pharmacokinetics and the impact of genotype on bedaquiline disposition. Here, we developed a population pharmacokinetic model of bedaquiline to describe the concentration-time data from Chinese adult patients diagnosed with MDR-TB. A total of 246 observations were collected from 99 subjects receiving the standard recommended dosage. Bedaquiline disposition was well described by a one-compartment model with first-order absorption. Covariate modeling identified that gamma-glutamyl transferase (GGT) and the single-nucleotide polymorphism (SNP) rs319952 in the
- Published
- 2022